Table 5.
Phosphorylation levels of sarcomeric proteins in patients with nonischemic cardiomyopathy before and after LVAD implantation.
Before LVAD | After LVAD | P-value* | Nonfailing | |
---|---|---|---|---|
Myosin Binding Protein C | 6.1 ± 1.2 | 6.7 ± 1.0 | 0.328 | 4.6 ± 0.6† |
Troponin T | 19.2 ± 3.0 | 18.0 ± 3.8 | 0.562 | 20.9 ± 7.0 |
Troponin I | 12.8 ± 4.1 | 21.6 ± 9.4 | 0.030 | 13.2 ± 1.9 |
Tropomyosin | 7.9 ± 2.6 | 8.5 ± 2.9 | 0.431 | 8.0 ± 1.9 |
Regulatory Myosin Light Chain | 0.5 ± 0.2 | 0.7 ± 0.3 | 0.109 | 0.6 ± 0.2 |
Serine 22,23 phosphorylated Troponin I | 3.7 ± 2.3 | 3.4 ± 1.5 | 0.747 | 2.8 ± 0.6 |
Serine 43 phosphorylated Troponin I | 7.5 ± 2.2 | 5.2 ± 1.9 | 0.044 | 12.0 ± 1.0‡ |
Phosphorylation levels expressed in arbitrary optical density units.
P-value for comparison between Before LVAD and After LVAD
P<0.01 for comparisons of Myosin Binding Protein C between Before LVAD vs. Nonfailing and After LVAD vs. Nonfailing
P<0.001 for comparisons of Serine 43 phosphorylated Troponin I between Before LVAD vs. Nonfailing and After LVAD vs. Nonfailing